New Nanogen CEO Says Management Changes Result from Shift in Strategy | GenomeWeb

NEW YORK, June 19 - Although recent management changes at Nanogen might make it seem the company is struggling to find its footing, the company's new CEO Randy White told GenomeWeb the changes in personnel come with the company's shift in focus from the research to the clinical diagnostics market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.